Terms: = Skin cancer AND PSA AND Treatment
81 results:
1. Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium.
Tohi Y; Kato T; Kobayashi K; Daizumoto K; Fukuhara H; Ohira S; Katayama S; Shimizu R; Takamoto A; Nishimura K; Ikeda K; Nagami T; Hayashida Y; Hirama H; Naito H; Tomida R; Sasaki Y; Yamamoto S; Shimizu S; Sugimoto M;
Jpn J Clin Oncol; 2024 Feb; 54(2):167-174. PubMed ID: 37840362
[TBL] [Abstract] [Full Text] [Related]
2. Scrotal Wall Metastasis from Adenocarcinoma of Unknown Origin, with Concurrent Extramammary Paget's Disease - a Case Report.
Loy LM; Vong KYE; Ding SLC; Yong ZPD; Kwan J; Tan BP
Gulf J Oncolog; 2023 Sep; 1(43):67-73. PubMed ID: 37732530
[TBL] [Abstract] [Full Text] [Related]
3. A retrospective study on the incidence, management and risk factors of skin rash in patients with advanced prostate cancer in Japan.
De Moor R; Koroki Y; Wu DB; Yu DY; Tohyama M; Ohyama C
BMC Urol; 2023 Apr; 23(1):73. PubMed ID: 37118710
[TBL] [Abstract] [Full Text] [Related]
4. cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study.
Huss V; Bower H; Hellgren K; Frisell T; Askling J; ;
Ann Rheum Dis; 2023 Jul; 82(7):911-919. PubMed ID: 36868796
[TBL] [Abstract] [Full Text] [Related]
5. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis.
Burmester GR; Cohen SB; Winthrop KL; Nash P; Irvine AD; Deodhar A; Mysler E; Tanaka Y; Liu J; Lacerda AP; Palac H; Shaw T; Mease PJ; Guttman-Yassky E
RMD Open; 2023 Feb; 9(1):. PubMed ID: 36754548
[TBL] [Abstract] [Full Text] [Related]
6. Economic Evaluation of Three BRAF + MEK Inhibitors for the treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective.
Halloush S; Alkhatib NS; Almutairi AR; Calamia M; Halawah H; Obeng-Kusi M; Hoyle M; Rashdan O; Koeller J; Abraham I
Ann Pharmacother; 2023 Sep; 57(9):1016-1024. PubMed ID: 36639851
[TBL] [Abstract] [Full Text] [Related]
7. Docetaxel chemotherapy plus androgen-deprivation therapy in high-volume disease metastatic hormone-sensitive prostate cancer in Chinese patients: an efficacy and safety analysis.
Guo Z; Lu X; Yang F; Qin L; Yang N; Wu J; Wang H
Eur J Med Res; 2022 Aug; 27(1):148. PubMed ID: 35953852
[TBL] [Abstract] [Full Text] [Related]
8. Polysaccharide-based nanocomposites for biomedical applications: a critical review.
Shokrani H; Shokrani A; Sajadi SM; Khodadadi Yazdi M; Seidi F; Jouyandeh M; Zarrintaj P; Kar S; Kim SJ; Kuang T; Rabiee N; Hejna A; Saeb MR; Ramakrishna S
Nanoscale Horiz; 2022 Sep; 7(10):1136-1160. PubMed ID: 35881463
[TBL] [Abstract] [Full Text] [Related]
9. NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer.
Lee LS; Sim AYL; Ong CW; Yang X; Ng CCY; Liu W; Rajasegaran V; Lim AMS; Aslim EJ; Ngo NT; Khor LY; Kanesvaran R; Allen JCJ; Tay KJ; Yuen JSP; Chong TW; Ho SSH; Teh BT; Chua MLK
Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):741-748. PubMed ID: 35091711
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration-resistant prostate cancer treated with Radium-223.
Al-Ezzi EM; Alqaisi HA; Iafolla MAJ; Wang L; Sridhar SS; Sacher AG; Fallah-Rad N; Jiang DM; Watson GA; Catton CN; Warde PR; Hamilton RJ; Fleshner NE; Zlotta AR; Hansen AR
Cancer Med; 2021 Sep; 10(17):5775-5782. PubMed ID: 34254464
[TBL] [Abstract] [Full Text] [Related]
11. Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody-Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide.
de Bono JS; Fleming MT; Wang JS; Cathomas R; Miralles MS; Bothos J; Hinrichs MJ; Zhang Q; He P; Williams M; Rosenbaum AI; Liang M; Vashisht K; Cho S; Martinez P; Petrylak DP
Clin Cancer Res; 2021 Jul; 27(13):3602-3609. PubMed ID: 33795255
[TBL] [Abstract] [Full Text] [Related]
12. Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.
Klotz L
World J Urol; 2022 Jan; 40(1):1-8. PubMed ID: 33492425
[TBL] [Abstract] [Full Text] [Related]
13. Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation.
Minagawa H; Kawai T; Matsumoto A; Makino K; Sato Y; Nagasaka K; Tokura M; Tanaka N; Ito E; Yamada Y; Nakamura M; Yamada D; Suzuki M; Murata T; Kume H
BMC Urol; 2021 Jan; 21(1):8. PubMed ID: 33413292
[TBL] [Abstract] [Full Text] [Related]
14. Association of previous treatment with anti-tumour necrosis factor inhibitors with the effectiveness of secukinumab in the treatment of psoriatic arthritis: systematic review and meta-analysis.
Xu Y; Li Y; Dong M; Gao Z; Chen X; Liu H; Shen M
Rheumatology (Oxford); 2020 Dec; 59(12):3657-3665. PubMed ID: 33038239
[TBL] [Abstract] [Full Text] [Related]
15. Moving Toward Precision Medicine in Psoriasis and Psoriatic Arthritis.
Ritchlin CT; Pennington SR; Reynolds NJ; FitzGerald O
J Rheumatol Suppl; 2020 Jun; 96():19-24. PubMed ID: 32482763
[TBL] [Abstract] [Full Text] [Related]
16. An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data.
Burmester GR; Curtis JR; Yun H; FitzGerald O; Winthrop KL; Azevedo VF; Rigby WFC; Kanik KS; Wang C; Biswas P; Jones T; Palmetto N; Hendrikx T; Menon S; Rojo R
Drug Saf; 2020 Apr; 43(4):379-392. PubMed ID: 32006348
[TBL] [Abstract] [Full Text] [Related]
17. In Vivo Effects of Polymerized Anthocyanin from Grape skin on Benign Prostatic Hyperplasia.
Choi YJ; Fan M; Tang Y; Yang HP; Hwang JY; Kim EK
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31615010
[TBL] [Abstract] [Full Text] [Related]
18. A Rich Array of Prostate cancer Molecular Biomarkers: Opportunities and Challenges.
Kohaar I; Petrovics G; Srivastava S
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013716
[TBL] [Abstract] [Full Text] [Related]
19. A novel case of NKX3.1-positive metastatic cutaneous prostate cancer.
Wong JK; Minni JP; Nowak MA
Dermatol Online J; 2018 Oct; 24(10):. PubMed ID: 30677815
[TBL] [Abstract] [Full Text] [Related]
20. Prostate cancer Screening Guidelines for African American Veterans: A New Perspective.
Reddy A; Roberts R; Shenoy D; Packianathan S; Giri S; Vijayakumar S
J Natl Med Assoc; 2020 Oct; 112(5):448-453. PubMed ID: 30409717
[TBL] [Abstract] [Full Text] [Related]
[Next]
